The central aims of SHORE-C are to evaluate the health outcomes of patients, especially those treated for cancer. Our broad psychosocial research portfolio covers 3 main areas:-
1. Clinical trials of cancer therapy
This includes the development of reliable, validated patient reported outcome measures and the co-ordination of the psychosocial/QoL sub-studies within national and international clinical trials.
2. Supportive interventions
This involves the development and evaluation of interventions to ameliorate the side-effects and impact of a cancer diagnosis and its treatment on patients and their families.
3. Communication skills training
We have a well-established evidence-based suite of communication skills training programmes and materials that are used worldwide and which have been shown to enhance the professional effectiveness and personal satisfaction of healthcare professionals. This in turn improves:- interactions with patients and healthcare professional colleagues, patient understanding about their diagnoses, management plans and clinical trial recruitment. We also make user-friendly information videos (DVDs and online) to assist patients contemplating entry into trials
Our eclectic research programme ensures that we have important and relevant data with which to inform the development of interventions and also to update the content of communication skills materials. Over the years we have built up an invaluable network of patient groups, clinicians, nurses and others in major cancer centres throughout the world that maximises our opportunities to recruit people into our studies and to disseminate findings widely. Much of our research has influenced policy and practice in cancer.
The academic background of SHORE-C members is primarily neuropsychology, experimental, social and health psychology not clinical psychology or psychiatry. This distinction influences both the areas in which we conduct research as well as the theoretical and methodological orientation of the group.